SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
52 hedge funds and large institutions have $438M invested in Sigilon Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 14 closing their positions.
Holders
52
Holders Change
+7
Holders Change %
+15.56%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
21
Increased
9
Reduced
11
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$8.24M |
2 |
2
BlackRock
New York
|
$28.7M |
3 |
APM
3
Avidity Partners Management
Dallas,
Texas
|
$19M |
4 |
![]()
4
JPMorgan Chase & Co
New York
|
$3.05M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$2.73M |